Conventional formulations, Challenges, and Nanomedicines in Infective and Non-Infective Skin Diseases Therapy

Mahfoozur       Rahman; Sarwar       Beg; Sohail       Akhter

doi:10.2174/1574891X14666190809115503

« Previous Next »

[1] 
Rahman Beg S. Anwar F, Al-Abbasi FA, Kumar V. Nanotechnology-based nano-bullets in anti-psoriatic drug delivery: state of the art. In: Nanoscience in Dermatology Elsevier.  Amsterdam, Netherlands 2016; pp. 157-66.
[2] 
Rahman M, Alam K, Ahmad MZ, Gupta G, Afzal M, Akhter S, et al. Classical to current approach for treatment of psoriasis: a review. Endocr Metab Immune Disord Drug Targets  2012; 12(3): 287-302.
[3] 
Rahman M, Zaki Ahmad M, Kazmi I, Akhter S, Beg S, Gupta G, et al. Insight into the biomarkers as the novel anti-psoriatic drug discovery tool: a contemporary viewpoint. Curr Drug Discov Technol  2012; 9(1): 48-62.
[4] 
Rahman M, Ahmad MZ, Kazmi I, Akhter S, Afzal M, Gupta G, et al. Advancement in multifunctional nanoparticles for the effective treatment of cancer. Expert Opin Drug Deliv  2012; 9(4): 367-81.
[5] 
Rahman M, Kumar V, Beg S, Sharma G, Katare OP, Anwar F. Emergence of liposome as targeted magic bullet for inflammatory disorders: current state of the art. Artif Cells Nanomed Biotechnol  2016; 13: 1-12.
[6] 
Rahman M, Akhter S, Ahmed J, Beg S. Nanomedicines based drug targeting of Psoriasis: potentials and emerging trends in nano-scale pharmacotherapy. Expert Opin Drug Deliv  2015; 12(4): 635-52.
[7] 
Rahman M, Beg S, Ahmad MZ, Kazmi I, Akhter S, Ahmed A. Omega - 3 fatty acids as pharmacotherapeutics in psoriasis: current status and scope of nanomedicine in its effective delivery. Curr Drug Targets  2013; 14(6): 708-22.
[8] 
Baboota S, Rahman M, Rathour AK, Sharma S, Sahni J, Ali J. Submicron size formulation of linseed oil containing omega-3 fatty acid for topical delivery. J Dispers Sci Technol  2012; 33(9): 1259-63.
[9] 
Rahman M, Beg S, Verma A, Kazmi I, Patel DK, Anwar F, et al. Therapeutic applications of liposomal based drug delivery and drug targeting for immune linked inflammatory maladies: a contemporary view point. Curr Drug Targets  2017; 18(13): 1558-71.
[10] 
Patel K, Kumar V, Verma A, Rahman M, Patel DK. Amarogentin as topical anticancer and anti-infective potential: scope of lipid based vesicular in its effective delivery. Recent Pat Antiinfect Drug Discov 2018. [Epub ahead of print]

Rights & Permissions Print Cite

Article Metrics

14

4

DOI https://dx.doi.org/10.2174/1574891X14666190809115503	Print ISSN 1574-891X
Publisher Name Bentham Science Publisher	Online ISSN 2212-4071

Recent Patents on Anti-Infective Drug Discovery

Conventional formulations, Challenges, and Nanomedicines in Infective and Non-Infective Skin Diseases Therapy

Related Journals

Related Books